Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy

Sponsor
The University of Texas Health Science Center, Houston
Status
Active, not recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT04920097
The proposed randomized control trial will evaluate auricular point acupressure (APA) on chemotherapy-induced neuropathy (CIN), rigorously considering point specificity and placebo effects by integrating self-report measures, psychophysical measures (QST), endogenous biomarkers (cytokines), and neuro-imaging to investigate APA's efficacy and underlying mechanism(s).
Intervention
In-person training for seed placement and APA, Post-training zoom session for seed placement and APA coaching, Usual Care, Virtual training for seed placement and APA
Condition
Chemotherapy-induced Neuropathy
Investigators
Constance Johnson, PhD, MS, RN, Nada Lukkahatai, PHD, MSN, RN

See list of participating sites